Macrogenics MGNX
NASDAQ MGNX
$4.40 +0.15 (+3.53%)
At close: Sep 4, 2026 · 4:00 PM EDT

Macrogenics (MGNX) Change in Receivables (2012 - 2026)

Macrogenics (MGNX) posted quarterly Change in Receivables of -$2.9 million for Q1 2026, down 147.28% year-over-year from $6.2 million in Q1 2025, and up 94.72% quarter-over-quarter from -$55.9 million in Q4 2025.

Analysis

Macrogenics (MGNX) Change in Receivables (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has reported Change in Receivables for 15 consecutive years, with -$2.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Receivables fell 147.28% year-over-year to -$2.9 million; the TTM figure through Mar 2026 stood at -$117000.0 (down 103.52% YoY), while the FY2025 annual figure was $9.1 million, up 249.6% from the prior year.
  • Change in Receivables advanced to -$2.9 million in Q1 2026 per MGNX's latest filing, from -$55.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $56.7 million in Q3 2025 and bottomed at -$55.9 million in Q4 2025.
  • Historically, Change in Receivables has averaged $2294.1 across 5 years, with a median of -$1.0 million in 2024.
  • On a YoY basis, Change in Receivables climbed as much as 2114.77% in 2025 and fell as far as 1157.5% in 2025.
  • Macrogenics' Change in Receivables stood at $42.4 million in 2022, then slumped by 135.26% to -$14.9 million in 2023, then jumped by 70.28% to -$4.4 million in 2024, then slumped by 1157.5% to -$55.9 million in 2025, then soared by 94.72% to -$2.9 million in 2026.
  • Business Quant data shows MGNX's Change in Receivables at -$2.9 million in Q1 2026, -$55.9 million in Q4 2025, and $56.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -53.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 117.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 31.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 37.16 Mn
10 Macrogenics 284.90 Mn 171.00 Mn - 25.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.95 Mn
Mar 31, 2026 -2.95 Mn
Dec 31, 2025 -55.86 Mn
Sep 30, 2025 56.70 Mn
Jun 30, 2025 1.99 Mn
Mar 31, 2025 6.23 Mn
Dec 31, 2024 -4.44 Mn
Sep 30, 2024 2.56 Mn
Jun 30, 2024 -1.03 Mn
Mar 31, 2024 -3.15 Mn
Dec 31, 2023 -14.94 Mn
Sep 30, 2023 18.90 Mn
Jun 30, 2023 -29.75 Mn
Mar 31, 2023 -20.06 Mn
Dec 31, 2022 42.38 Mn
Sep 30, 2022 -4.55 Mn
Jun 30, 2022 3.48 Mn
Mar 31, 2022 4.52 Mn
Dec 31, 2021 -3.37 Mn
Sep 30, 2021 -31.49 Mn